#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phenylketonuria Congenital aplastic anaemia Giant cell tumour of tendon sheath Non-Hodgkin's lymphoma unspecified histology indolent Desmoid tumour Cardiac arrest Small cell lung cancer recurrent Hypotransferrinaemia Pericarditis Chronic myeloid leukaemia Familial dilated cardiomyopathy Methylmalonic acidaemia Malignant central nervous system neoplasm Vascular malformation Breast cancer More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Treatment Wolfram syndrome – Diagnostics Myelodysplastic syndrome – Diagnostics Biotinidase deficiency – Trials in Disease Glomerulonephritis rapidly progressive – Diagnostics Castleman’s disease – Diagnostics Fabry’s disease – Basic Information Synovial sarcoma metastatic Osteosarcoma recurrent – Treatment Familial amyotrophic lateral sclerosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Paraffin White Soft GSKVX000000034797 Ambrosia Artemisiifolia (302) LY3841136 SODIUM Ucart20X22 Certolizumab Pegol Syn2 ALE1 Tilmanocept Annamycin ETX-19477 Ltx-315 IMEROPRUBART Cln-081 Miransertib Adct-402 Vemurafenib VIPOGLANSTAT Festuca Rubra Pollen Glenzocimab More therapies…

    Learn about Your Condition

    Liver transplant PIK3CA-activated mutation Hyperlipidaemia Drug dependence Supranuclear palsy Renal cell carcinoma stage IV Hereditary optic atrophy Connective tissue disorder Bronchostenosis Rett syndrome Gastrointestinal carcinoma Lung adenocarcinoma stage IV Transitional cell carcinoma Erectile dysfunction Primary hypogonadism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on Venetoclax and Rituximab for Patients with Waldenström’s Macroglobulinemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Waldenstrom’s macroglobulinaemia
    Investigated Drugs:
    • Cyclophosphamide
    • Dexamethasone
    • Rituximab
    Germany Greece

  • Study on Early Stage Follicular Lymphoma: Evaluating Radiotherapy with Rituximab or Obinutuzumab for Patients with Early Stage Nodal Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Obinutuzumab
    • Rituximab
    Germany

  • Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute leukaemia
    • Myeloid leukaemia
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Ponatinib
    Belgium France Italy The Netherlands Spain Sweden

  • Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    • B-cell lymphoma
    • Plasma cell myeloma
    Investigated Drugs:
    • Autologous T-Cells Encoding A Chimeric Antigen Receptor Targeting Human B Cell Maturation Antigen
    • Tisagenlecleucel
    • Rapcabtagene Autoleucel
    Austria Belgium Denmark Finland France Germany +6

  • Study of Iberdomide and Isatuximab for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    • Dexamethasone
    • Iberdomide
    Austria Germany

  • Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaemia
    • Myelofibrosis
    • Thalassaemia
    Investigated Drugs:
    • Luspatercept
    Bulgaria France Germany Greece Italy The Netherlands +2
Previous Page
1 … 22 23 24 25 26 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!